Sensible Biotechnologies Raises $47M to Expand Next-Generation Platform for mRNA Medicines

VECTORPositive

AI Analysis

Summary

Sensible Biotechnologies raised $47 million to expand its VECTOR platform, which combines AI-enabled mRNA design with manufacturing of naturally modified mRNA in living cells for developing novel therapeutics.

Importance:5/10

Sentiment:

0.60

mRNAFundingPlatform TechnologyManufacturingAI

Related Companies

$INBP $GBIO $TRAX

Read the original article

Published by GEN - Genetic Engineering & Biotech News on October 6, 2026 11:05 AM

Read Original